Annual FCF
-$707.00 K
+$194.00 K+21.53%
31 December 2023
Summary:
XTL Biopharmaceuticals annual free cash flow is currently -$707.00 thousand, with the most recent change of +$194.00 thousand (+21.53%) on 31 December 2023. During the last 3 years, it has risen by +$144.00 thousand (+16.92%). XTLB annual FCF is now at all-time high.XTLB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly free cash flow is not available.XTLB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals TTM free cash flow is not available.XTLB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.5% | - | - |
| 3 y3 years | +16.9% | - | - |
| 5 y5 years | +13.4% | - | - |
XTLB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.6% | ||||
| 5 y | 5 years | at high | +32.6% | ||||
| alltime | all time | at high | +96.7% |
XTL Biopharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$707.00 K(-21.5%) | - | - |
| Dec 2022 | -$901.00 K(-14.1%) | - | - |
| Dec 2021 | -$1.05 M(+23.3%) | - | - |
| Dec 2020 | -$851.00 K(-6.5%) | - | - |
| Dec 2019 | -$910.00 K(+11.5%) | - | - |
| Dec 2018 | -$816.00 K(-27.5%) | - | - |
| Dec 2017 | -$1.13 M(-37.4%) | - | - |
| Dec 2016 | -$1.80 M(-6.7%) | - | - |
| Dec 2015 | -$1.93 M(-22.3%) | - | - |
| Dec 2014 | -$2.48 M(-4.0%) | -$674.00 K(+48.1%) | -$2.48 M(+6.6%) |
| Sept 2014 | - | -$455.00 K(-17.0%) | -$2.33 M(-11.5%) |
| June 2014 | - | -$548.00 K(-31.8%) | -$2.63 M(-4.4%) |
| Mar 2014 | - | -$803.00 K(+54.1%) | -$2.75 M(+6.5%) |
| Dec 2013 | -$2.58 M(+62.2%) | -$521.00 K(-31.3%) | -$2.58 M(+1.1%) |
| Sept 2013 | - | -$758.00 K(+13.1%) | -$2.55 M(+12.6%) |
| June 2013 | - | -$670.00 K(+5.7%) | -$2.27 M(+16.8%) |
| Mar 2013 | - | -$634.00 K(+28.9%) | -$1.94 M(+22.0%) |
| Dec 2012 | -$1.59 M | -$492.00 K(+4.2%) | -$1.59 M(+82.4%) |
| Sept 2012 | - | -$472.00 K(+37.2%) | -$873.00 K(+34.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | -$344.00 K(+21.1%) | -$647.00 K(-45.6%) |
| Mar 2012 | - | -$284.00 K(-225.1%) | -$1.19 M(-10.1%) |
| Dec 2011 | -$1.32 M(-46.8%) | $227.00 K(-192.3%) | -$1.32 M(-14.6%) |
| Sept 2011 | - | -$246.00 K(-72.3%) | -$1.55 M(+2.4%) |
| June 2011 | - | -$887.00 K(+112.2%) | -$1.51 M(+105.7%) |
| Mar 2011 | - | -$418.00 K(+100.0%) | -$736.00 K(+8.1%) |
| Sept 2010 | - | -$209.00 K(+91.7%) | -$681.00 K(-3.7%) |
| June 2010 | - | -$109.00 K(-19.3%) | -$707.00 K(-0.7%) |
| Mar 2010 | - | -$135.00 K(-40.8%) | -$712.00 K(-71.4%) |
| Dec 2009 | -$2.49 M(-76.5%) | -$228.00 K(-3.0%) | -$2.49 M(+10.1%) |
| Sept 2009 | - | -$235.00 K(+106.1%) | -$2.26 M(+11.6%) |
| June 2009 | - | -$114.00 K(-94.0%) | -$2.02 M(+6.0%) |
| Mar 2009 | - | -$1.91 M | -$1.91 M |
| Dec 2008 | -$10.58 M(-50.8%) | - | - |
| Dec 2007 | -$21.52 M(+70.7%) | - | - |
| Dec 2006 | -$12.61 M(+20.0%) | - | - |
| Dec 2005 | -$10.50 M(-28.4%) | - | - |
| Dec 2004 | -$14.68 M(+9.5%) | - | - |
| Dec 2003 | -$13.41 M | - | - |
FAQ
- What is XTL Biopharmaceuticals annual free cash flow?
- What is the all time high annual FCF for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual FCF year-on-year change?
- What is the all time high quarterly FCF for XTL Biopharmaceuticals?
- What is the all time high TTM FCF for XTL Biopharmaceuticals?
What is XTL Biopharmaceuticals annual free cash flow?
The current annual FCF of XTLB is -$707.00 K
What is the all time high annual FCF for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual free cash flow is -$707.00 K
What is XTL Biopharmaceuticals annual FCF year-on-year change?
Over the past year, XTLB annual free cash flow has changed by +$194.00 K (+21.53%)
What is the all time high quarterly FCF for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly free cash flow is $227.00 K
What is the all time high TTM FCF for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM free cash flow is -$647.00 K